Vasohibin-1 is a recently identified negative feedback regulator of angiogenesis induced by VEGF-A and bFGF. In this study, we first evaluated mRNA expression of vasohibin-1 and CD31 in 39 Japanese female breast carcinoma specimens including 22 invasive ductal carcinoma (IDC) and 17 ductal carcinoma in situ (DCIS) using a real-time quantitative RT-PCR (QRT-PCR) with LightCycler system. In addition, we also immunolocalized vasohibin-1 and CD31 and compared their immunoreactivity to nuclear grades and histological grades of 100 carcinoma cases (50 IDC and 50 DCIS). There were no statistically significant differences of CD31 mRNA expression and the number of CD31 positive vessels between DCIS and IDC (P = 0.250 and P = 0.191, respectively), whereas there was a statistically significant difference in vasohibin-1 mRNA expression and the number of vasohibin-1 positive vessels in DCIS and IDC (P = 0.022 and P £ 0.001, respectively). There was a significant positive correlation between vasohibin-1 mRNA level and Ki-67 labeling index in DCIS (r 2 = 0.293, P £ 0.001). In addition, vasohibin-1 mRNA expression was correlated with high nuclear and histological grades in DCIS cases and a significant positive correlation was detected between the number of vasohibin-1 positive vessels and Ki-67 labeling index or nuclear grade or Van Nuys classification of carcinoma cells (P £ 0.001, respectively). These results all indicate the possible correlation between aggressive biological features in DCIS including increased tumor cell proliferation and the status of neovascularization determined by vasohibin-1 immunoreactivity. (Cancer Sci 2010; 101: 1051-1058 B reast cancer is one of the most common malignancies in woman worldwide and its morbidity has recently increased.(1) Numerous factors have been reported to be associated with development of breast cancer including angiogenesis. Angiogenesis or the formation of new blood vessel networks not only plays a pivotal role in human normal development, but also in pathological conditions such as inflammatory diseases and neoplasms.(2) A switch to the actively angiogenic phenotype is in general considered to be dependent upon an in situ balance between stimulatory and inhibitory factors of angiogenesis. (2,3) Therefore, numerous studies have been reported on the mechanisms of control or regulation of angiogenesis since the discovery of endothelium-specific proangiogenic factors, namely vascular endothelial growth factor (VEGF) and angiopoietin family proteins.(2) In addition, other molecules involved in this process of angiogenesis, including pigment epithelium derived factor (PEDF), platelet factor 4, angiostantin and endostatin, have been proposed as angiogenesis inhibitors. (2,4) Vasohibin-1 has been very recently identified as one of the first established negative feedback regulators of angiogenesis, from an extensive microarray analysis originally designed to identify genes up-regulated by VEGF in cultured vascular endothelial cells. (2,(5)(6)(7)(8) Vasohibin-1 was subsequently demonst...